PUBLISHER: Meticulous Research | PRODUCT CODE: 1513314
PUBLISHER: Meticulous Research | PRODUCT CODE: 1513314
Advanced Wound Care Market Size, Share, Forecast, & Trends Analysis by Product (Dressings [Foam, Film, Hydrogel] NPWT, Hyperbaric Oxygen, Cleanser, Growth Factor, Skin Substitute) Application (Surgical, Trauma, Burn, DFU) End User- Global Forecast to 2031
The advanced wound care market is projected to reach $18.19 billion by 2031 at a CAGR of 6.6% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The rising number of chronic wounds associated with the geriatric population, growing traumatic injuries, rising number of surgeries, benefits offered by the advanced wound care products over the traditional products, technological advancements in wound care management products, and increasing wound care awareness programs are some of the factors driving the growth of this market. However, the high cost of advanced wound care devices and therapies and the availability of alternative treatment options restrain the growth of this market.
Furthermore, therapy-based solutions, rising demand for advanced wound care dressings, and partnerships and collaborations between companies are expected to generate growth opportunities for the players operating in this market. However, the lack of healthcare infrastructure in developing countries is a major challenge impacting market growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the advanced wound care market are 3M Company (U.S.), Cardinal Health, Inc. (U.S.), Smith & Nephew plc (U.K.), Integra LifeSciences Corporation (U.S.), Molnlycke Health Care AB (Sweden), Coloplast A/S (Denmark), Convatec Group plc (U.K.), DeRoyal Industries, Inc. (U.S.), Medline Industries, LP (U.S.), B. Braun Melsungen AG (Germany), Organogenesis Inc. (U.S.), Winner Medical Co., Ltd. (China), HARTMANN USA, Inc. (U.S.) MIMEDX Group, Inc. (U.S.), and Mil Laboratories Pvt. Ltd. (India).
Among all the products studied in this report, the active wound care segment is projected to register the highest CAGR of over 9.1% during the forecast period of 2024-2031. Factors such as technological advancements in wound care, rising demand for skin substitutes, and growth factors in wound care are some of the drivers for the growth of this segment.
Among all the applications studied in this report, in 2024, the acute wounds segment is expected to account for the larger share of the advanced wound care market. The large market share of this segment can be attributed to the increasing number of traumatic injuries such as falls, accidents, and burns and the increasing number of surgeries.
Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the advanced wound care market. The large market share of this segment can be attributed to the growing number of patient visits for wound care and management and surgical procedures in hospitals, the presence of highly skilled healthcare professionals, ease in accessibility, the advancements in wound care, and the adoption of foam dressings, Negative Pressure Wound Therapy (NPWT) devices, sterile saline wound solutions, and skin substitutes by the hospitals & clinics.
An in-depth analysis of the geographical scenario of the advanced wound care market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 42.3% of the advanced wound care market. In the region, North America's significant market share can be attributed to several key factors, including the presence of major advanced wound care companies such as 3M Company (U.S.), Cardinal Health, Inc. (U.S.), and HARTMANN USA, Inc. (U.S.); high adoption of advanced wound care devices and products in hospitals & clinics; increasing cases of chronic wounds such as diabetic foot ulcers; and favorable reimbursement policies.
In 2024, the U.S. is expected to account for the largest share of the advanced wound care market in North America. The large share of this regional market is attributed to the presence of major advanced wound care companies, increasing prevalence of chronic wounds, high adoption of advanced wound care products in hospitals & clinics, and growing traumatic injuries.
Advanced Wound Care Market Assessment-by Product
Note: Other advanced wound dressings include honey dressings, composite dressings, post-op dressings, surfactant dressings, & synthetic dressings.
Note: Other wound therapy devices include Electromagnetic therapy (EMT), compression therapy, and cleansing & debridement systems.
Note: Other advanced wound care products include wound measurement accessories, skin protectants, rapid dry films, & tapes.
Advanced Wound Care Market Assessment-by Application
Note: Other chronic wounds include arterial ulcers and acute & sub-acute ulcers.
Advanced Wound Care Market Assessment-by End User
Note: Other end users include sports and athletic institutions, defense, and long-term care centers.
Advanced Wound Care Market Assessment-by Geography
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)